Familial Dysalbuminemic Hyperthyroxinemia: An Underdiagnosed Entity

Resistance to thyroid hormone (RTH) is a syndrome characterized by impaired sensitivity of tissues to thyroid hormone (TH). The alteration of TH-binding proteins, such as in Familial Dysalbuminemic Hyperthyroxinemia (FDH), can mimic the abnormal serum thyroid tests typical of RTH. We aimed to characterize a population referred to our center with suspected RTH and estimate the proportion of patients with FDH. For 303 different families, we collected clinical and hormonal data and sequenced the thyroid hormone receptor β gene (THRB) and exon 7 of the albumin gene (ALB). We found 56 THRB variants (i.e., 38% of the 303 index cases, called RTHβ group). Among the samples screened for FDH variants, 18% had the variant R218H in ALB (FDH group); in addition, 71% of the cases had neither variant (non-FDH/RTHβ group). Patients with FDH had significantly lower free T3 (fT3) and free T4 (fT4) levels and more often an isolated elevation of fT4 than RTHβ patients. Clinically, patients with FDH had fewer symptoms than patients with RTHβ. Our study suggests that FDH should be systematically considered when examining patients suspected of having RTH. In most cases, they present no clinical symptoms, and their biochemical alterations show an elevation of fT4 levels, while fT3 levels are 1.11 times below the upper limit of the assay.

[1]  Alexandros Kouris,et al.  VarSome: the human genomic variant search engine , 2018, bioRxiv.

[2]  D. Maiter,et al.  Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm , 2018, Endocrine reviews.

[3]  O. Janssen,et al.  Directional thyroid hormone distribution via the blood stream to target sites , 2017, Molecular and Cellular Endocrinology.

[4]  M. Galliano,et al.  Clinical, Genetic, and Protein Structural Aspects of Familial Dysalbuminemic Hyperthyroxinemia and Hypertriiodothyroninemia , 2017, Front. Endocrinol..

[5]  M. Polak,et al.  False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences , 2017, Clinical chemistry and laboratory medicine.

[6]  A. Hollenberg,et al.  The actions of thyroid hormone signaling in the nucleus , 2017, Molecular and Cellular Endocrinology.

[7]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[8]  S. Refetoff,et al.  Inherited defects of thyroxine-binding proteins. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[9]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[10]  F. Wondisford,et al.  Thyroid hormone receptors and resistance to thyroid hormone disorders , 2014, Nature Reviews Endocrinology.

[11]  Mark Gurnell,et al.  Pitfalls in the measurement and interpretation of thyroid function tests☆ , 2013, Best practice & research. Clinical endocrinology & metabolism.

[12]  S. Refetoff,et al.  The syndromes of reduced sensitivity to thyroid hormone. , 2013, Biochimica et biophysica acta.

[13]  G. Brent,et al.  Mechanisms of thyroid hormone action. , 2012, The Journal of clinical investigation.

[14]  R. Weiss,et al.  Homozygous thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  C. Sturgeon,et al.  Analytical error and interference in immunoassay: minimizing risk , 2011, Annals of clinical biochemistry.

[16]  F. Sweep,et al.  Spuriously high free thyroxine values in familial dysalbuminemic hyperthyroxinemia. , 2011, Clinical chemistry.

[17]  A. Pinchera,et al.  Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge. , 2009, Clinical chemistry.

[18]  P. Clark,et al.  Influence of thyroid hormone autoantibodies on 7 thyroid hormone assays. , 2008, Clinical chemistry.

[19]  R. Weiss,et al.  Mosaicism of a thyroid hormone receptor-beta gene mutation in resistance to thyroid hormone. , 2006, The Journal of clinical endocrinology and metabolism.

[20]  S. Hansen,et al.  Reference methods for the measurement of free thyroid hormones in blood: evaluation of potential reference methods for free thyroxine. , 2004, Clinical biochemistry.

[21]  P. Macchia,et al.  Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes. , 2000, The Journal of clinical endocrinology and metabolism.

[22]  P. Macchia,et al.  Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. , 1999, The Journal of clinical endocrinology and metabolism.

[23]  T. Nagaya,et al.  Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor. , 1996, The Journal of clinical endocrinology and metabolism.

[24]  S. Seino,et al.  Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Refetoff,et al.  Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. , 1967, The Journal of clinical endocrinology and metabolism.

[26]  Hirotoshi Nakamura,et al.  Falsely elevated thyroid hormone levels caused by anti-ruthenium interference in the Elecsys assay resembling the syndrome of inappropriate secretion of thyrotropin. , 2012, Endocrine journal.